{"id":"W2153865661","doi":"10.1200/jco.2007.14.4824","title":"Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":573,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Sanofi; AstraZeneca","keywords":"Medicine; Gefitinib; Docetaxel; Internal medicine; Performance status; Lung cancer; Interim analysis; Placebo; Chemoradiotherapy; Surgery; Oncology; Chemotherapy; Cancer; Clinical trial; Epidermal growth factor receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001003203,0.000156193,0.001540953,0.000125947,0.00003957357,0.000006352112,0.00008021138,0.0002209595,0.000408609],"category_scores_gemma":[0.0003349259,0.000102589,0.0001934163,0.0001374767,0.0002454322,0.0001209852,0.00001990745,0.0005165501,0.000001103295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002852862,"about_ca_system_score_gemma":0.003239344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001740722,"about_ca_topic_score_gemma":0.0001551703,"domain_scores_codex":[0.9971541,0.0001677479,0.002037222,0.0002057027,0.0002071593,0.0002280776],"domain_scores_gemma":[0.9971268,0.0007732587,0.001399535,0.0001313107,0.0003219937,0.0002470879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7778994,0.02129056,0.06148108,0.0003956021,0.001508622,0.003328592,0.004371811,0.0001088427,0.001508533,0.00006294561,0.008458226,0.1195857],"study_design_scores_gemma":[0.9239024,0.02480921,0.01020983,0.0004375014,0.0008062646,0.0002965793,0.0003865482,0.0009541483,0.0009024261,0.000009952805,0.03709943,0.0001856991],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932073,0.001622103,0.0003108735,0.001767671,0.0009521753,0.0009519549,0.00003024589,0.00000462287,0.001153091],"genre_scores_gemma":[0.9819543,0.01262007,0.001009932,0.001091025,0.0006117297,0.00006880928,0.000006004421,0.00001624895,0.002621886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1460029,"threshold_uncertainty_score":0.5746458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08398044194763006,"score_gpt":0.4845825549230046,"score_spread":0.4006021129753746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}